CEO since 2023. (Born 1964) Education and experience: Peter Ekolind is a registered nurse, a certified market economist and holds an Executive MBA from the School of Economics at Lund University. He has many years of broad experience in marketing, sales and leadership from several global pharmaceutical, biotechnology and medical technology companies in various senior roles. Among other things, he has been managing director of Getinge Sweden and Avidicare. In recent years, the focus has been on work in smaller start-ups.
Current assignments: Board member of Panion Animal Health AB and CombiGene Personal AB.
Previous assignments during the last five years: COO Xintela AB, Board member Nordic Gamekeeper Holding AB, senior management consultant in NordiCare AB, Interim CEO of Targinta AB and COO of CombiGene.
Owner and active in the following companies: Pekoli AB.
Own and/or related parties’ holdings in the Company: 43 811 shares.
Chief Scientific Officer since 2024.
Education and experience: Annika Ericsson holds a PhD in medical biochemistry from Karolinska Institutet. Her thesis topic concerned enzyme and gene therapy for acute intermittent porphyria. She has postdoc experience from Mount Sinai School of Medicine in New York and 17 years of experience in the biotech industry, having worked with Zymenex A/S and Chiesi. There she has worked laboratory with the development and upscaling of production processes for protein drugs and been project manager for preclinical studies in various lysosomal diseases. Annika has broad experience of planning, organizing and conducting large research projects.